,EC_number,b_number,KEGG_ID,name,Commentary
0,1.1.1.6,b3945,C00238,Potassium cation,activates NADH production
1,2.1.1.13,b4019,C00238,Potassium cation,at 67 mM 1.4 fold activity
2,2.3.2.12,,C00238,Potassium cation,reaction is completely dependent upon potassium ions
3,2.3.2.12,,C00238,Potassium cation,stimulation not so marked as that caused by NH4+ ions
4,2.7.1.73,b0477,C00238,Potassium cation,the enzyme requires both Mg2+ and K+
5,1.1.1.6,b3945,C00014,Ammonia,activates NADH production
6,2.1.1.13,b4019,C00014,Ammonia,at 67 mM 1.5 fold activity
7,2.1.1.61,b2324,C00014,Ammonia,
8,2.3.2.12,,C00014,Ammonia,reaction is completely dependent upon ammonium ions
9,2.3.2.12,,C00014,Ammonia,
10,2.3.2.12,,C00014,Ammonia,combination of NH4+ ions with spermine produces an additive activity increase
11,2.7.1.11,b3916,C00014,Ammonia,
12,2.7.1.11,b1723,C00014,Ammonia,
13,2.7.1.11,b3916,C00014,Ammonia,can replace K+
14,2.7.1.11,b1723,C00014,Ammonia,can replace K+
15,2.7.1.15,b3752,C00014,Ammonia,activates
16,2.7.1.39,b0003,C00014,Ammonia,30% of the activity obtained with 0.5 M K+
17,3.1.13.5,b1804,C00014,Ammonia,stimulates
18,3.1.26.3,b2567,C00014,Ammonia,maximum activity at 0.15-0.3 M
19,3.1.26.3,b2567,C00014,Ammonia,cleavage pattern depends on concentration
20,3.1.26.3,b2567,C00014,Ammonia,required
21,3.1.26.3,b2567,C00014,Ammonia,stimualtion at 20 mM
22,3.1.26.3,b2567,C00014,Ammonia,
23,3.1.26.7,,C00014,Ammonia,stimulates in presence of Mg2+
24,3.6.5.3,,C00014,Ammonia,
25,1.1.1.38,b1479,C00049,L-Aspartate,
26,1.1.1.38,b1479,C02441,N-Ethylmaleimide,"1 mM, 8.9fold increase in oxaloacetate reduction activity"
27,1.3.1.9,b1288,C02441,N-Ethylmaleimide,stimulation
28,2.3.1.29,b3617,C02441,N-Ethylmaleimide,
29,3.5.4.5,b2143,C02441,N-Ethylmaleimide,"0.10-0.20 mM, activity 114%"
30,3.6.4.9,,C02441,N-Ethylmaleimide,2fold increase in activity after modification of GroEL with 2 mM N-ethylmaleimide
31,1.1.1.38,b1479,C03444,p-Chloromercuribenzoate,"0.02 mM, 2.5fold increase in oxaloacetate reduction activity"
32,3.5.4.5,b2143,C03444,p-Chloromercuribenzoate,"0.105 mM, activity 112%"
33,1.1.1.49,b1852,C00315,Spermidine,activation constant: 0.2 mM
34,1.6.5.11,,C00315,Spermidine,enzyme optimally activated by phospholipids is additionally activated 2fold
35,2.1.1.35,b3965,C00315,Spermidine,slight activation at 20 mM in presence of 50 mM ammonium acetate
36,2.1.1.35,b3965,C00315,Spermidine,"activates, inhibitory at optimal Mg2+ concentration"
37,2.1.1.193,b2946,C00315,Spermidine,"in the presence of spermidine, Mg2+ is not required for activity. Activity could be restored up to 60% of that with Mg2+ by addition of spermidine at 30 mM"
38,2.7.7.8,b3164,C00315,Spermidine,"0.1-1.0 mM, activates ADP-phosphate exchange 2fold"
39,3.1.13.1,b1286,C00315,Spermidine,can replace missing Mg2+ to a small extent
40,3.1.26.5,b3704,C00315,Spermidine,M1 RNA subunit can catalyze the cleavage of tRNA precursor molecules in the presence of 5 mM spermine or spermidine
41,3.2.2.21,b2068,C00315,Spermidine,stimulates activity
42,3.4.21.53,b0439,C00315,Spermidine,"activation, at physiological concentration, ATP hydrolysis and protease activity"
43,6.1.1.5,b0026,C00315,Spermidine,at least 2 bound Mg2+ or spermidines required for binding of tRNA to the enzyme
44,6.1.1.5,b0026,C00315,Spermidine,activates
45,6.1.1.19,b1876,C00315,Spermidine,supports aminoacylation in presence of crude tRNA not in presence of resolved tRNA
46,1.1.1.57,b4323,C00928,Mercaptoethanol,
47,1.1.1.78,,C00928,Mercaptoethanol,slight activation
48,1.1.1.159,b1619,C00928,Mercaptoethanol,activation
49,1.2.1.3,,C00928,Mercaptoethanol,27% increased activity at 1 mM
50,1.2.1.B6,,C00928,Mercaptoethanol,"1 mM, activity increases by 27%"
51,1.2.1.10,b0351,C00928,Mercaptoethanol,reduces lag phase before attainment of steady state rate in conjunction with NAD+
52,1.2.1.10,b1241,C00928,Mercaptoethanol,reduces lag phase before attainment of steady state rate in conjunction with NAD+
53,2.1.1.33,b2960,C00928,Mercaptoethanol,activates
54,2.1.1.35,b3965,C00928,Mercaptoethanol,activates
55,2.3.1.41,b2323,C00928,Mercaptoethanol,activation
56,2.3.1.41,b2323,C00928,Mercaptoethanol,"required in high concentration, 0.5 M"
57,2.3.1.41,b2323,C00928,Mercaptoethanol,required
58,2.5.1.54,b0754,C00928,Mercaptoethanol,activates
59,2.5.1.54,b1704,C00928,Mercaptoethanol,activates
60,2.5.1.54,b2601,C00928,Mercaptoethanol,activates
61,2.7.7.7,b4259,C00928,Mercaptoethanol,
62,2.7.7.7,b4372,C00928,Mercaptoethanol,
63,2.7.7.7,b0640,C00928,Mercaptoethanol,
64,2.7.7.7,b1099,C00928,Mercaptoethanol,
65,2.7.7.7,b3701,C00928,Mercaptoethanol,
66,2.7.7.7,b3863,C00928,Mercaptoethanol,
67,2.7.7.7,b0060,C00928,Mercaptoethanol,
68,2.7.7.7,b0215,C00928,Mercaptoethanol,
69,2.7.7.7,b1842,C00928,Mercaptoethanol,
70,2.7.7.7,b0470,C00928,Mercaptoethanol,
71,2.7.7.7,b0231,C00928,Mercaptoethanol,
72,2.7.7.7,b0184,C00928,Mercaptoethanol,
73,2.7.7.7,b4259,C00928,Mercaptoethanol,required for maximal activity
74,2.7.7.7,b4372,C00928,Mercaptoethanol,required for maximal activity
75,2.7.7.7,b0640,C00928,Mercaptoethanol,required for maximal activity
76,2.7.7.7,b1099,C00928,Mercaptoethanol,required for maximal activity
77,2.7.7.7,b3701,C00928,Mercaptoethanol,required for maximal activity
78,2.7.7.7,b3863,C00928,Mercaptoethanol,required for maximal activity
79,2.7.7.7,b0060,C00928,Mercaptoethanol,required for maximal activity
80,2.7.7.7,b0215,C00928,Mercaptoethanol,required for maximal activity
81,2.7.7.7,b1842,C00928,Mercaptoethanol,required for maximal activity
82,2.7.7.7,b0470,C00928,Mercaptoethanol,required for maximal activity
83,2.7.7.7,b0231,C00928,Mercaptoethanol,required for maximal activity
84,2.7.7.7,b0184,C00928,Mercaptoethanol,required for maximal activity
85,2.7.7.12,b0758,C00928,Mercaptoethanol,2fold at 10 mM
86,2.7.7.47,,C00928,Mercaptoethanol,enhances the degree of streptomycin inactivation
87,3.1.4.14,b0404,C00928,Mercaptoethanol,required
88,3.1.11.2,b1749,C00928,Mercaptoethanol,required
89,3.1.11.6,b0422,C00928,Mercaptoethanol,required for 100% activity
90,3.1.11.6,b2509,C00928,Mercaptoethanol,required for 100% activity
91,3.1.21.2,b2159,C00928,Mercaptoethanol,slight activation
92,3.4.11.10,,C00928,Mercaptoethanol,"activates, 30% activation at 17 mM"
93,3.4.24.B20,,C00928,Mercaptoethanol,
94,4.1.1.31,b3956,C00928,Mercaptoethanol,activates
95,4.2.1.7,b3091,C00928,Mercaptoethanol,"sulfhydryl compounds required, 50 mM 2-mercaptoethanol in presence of 0.8 mM FeSO4 is optimal"
96,5.4.4.2,b0593,C00928,Mercaptoethanol,"stimulates, 2.25fold stimulation at 20-30 mM"
97,5.4.4.2,b2265,C00928,Mercaptoethanol,"stimulates, 2.25fold stimulation at 20-30 mM"
98,6.1.1.9,b4258,C00928,Mercaptoethanol,stimulates
99,1.1.1.57,b4323,C00284,EDTA,
100,2.3.1.41,b2323,C00284,EDTA,"7 mM, stimulates"
101,2.3.1.41,b2323,C00284,EDTA,activation
102,2.4.1.129,b0149,C00284,EDTA,stimulation in the presence of high concentrations of methanol and detergents
103,2.4.99.17,b0405,C00284,EDTA,100% activity in the presence of 100 mM EDTA
104,2.5.1.55,b1215,C00284,EDTA,"1 mM, 40% stimulation"
105,2.5.1.55,b1215,C00284,EDTA,
106,3.1.3.27,b1278,C00284,EDTA,1 mM
107,3.1.3.27,b0418,C00284,EDTA,1 mM
108,3.1.3.27,b2560,C00284,EDTA,1 mM
109,3.1.3.27,b1278,C00284,EDTA,distinctly stimulatory at 1 mM
110,3.1.3.27,b0418,C00284,EDTA,distinctly stimulatory at 1 mM
111,3.1.3.27,b2560,C00284,EDTA,distinctly stimulatory at 1 mM
112,3.1.3.81,b1278,C00284,EDTA,35% stimulation at 2 mM
113,3.1.26.3,b2567,C00284,EDTA,less than 1 mM
114,3.1.26.11,b2268,C00284,EDTA,"with 0.2 mM, at 37°C, pH 7.4, 11% relative activity when compared to Co2+"
115,3.4.23.49,b0565,C00284,EDTA,enhances activity
116,3.5.1.2,b1524,C00284,EDTA,slight activation
117,3.5.1.2,b0485,C00284,EDTA,slight activation
118,3.5.4.1,b0337,C00284,EDTA,"1 mM, relative activity 101%"
119,3.5.4.5,b2143,C00284,EDTA,"10 mM, activity 108%"
120,3.5.4.26,b0414,C00284,EDTA,
121,4.1.2.25,b3058,C00284,EDTA,increases activity
122,4.2.3.12,b2765,C00284,EDTA,"1-5 mM, 110-120% activation"
123,5.3.1.13,b2708,C00284,EDTA,0.01 mM
124,5.3.1.13,b3197,C00284,EDTA,0.01 mM
125,5.3.1.13,b2708,C00284,EDTA,
126,5.3.1.13,b3197,C00284,EDTA,
127,5.3.1.13,b2708,C00284,EDTA,EDTA treatment increases the activity of c3406 protein by approximately 2.5fold
128,5.3.1.13,b3197,C00284,EDTA,EDTA treatment increases the activity of c3406 protein by approximately 2.5fold
129,1.1.1.78,,C00051,Glutathione,slight activation
130,1.1.1.205,b2508,C00051,Glutathione,
131,1.2.1.22,b1415,C00051,Glutathione,
132,2.1.1.35,b3965,C00051,Glutathione,activates
133,2.7.1.25,b2750,C00051,Glutathione,reduced glutathione increases the activity significantly
134,3.5.1.16,b3957,C00051,Glutathione,
135,4.1.1.98,b3843,C00051,Glutathione,slight stimulation of activity at 10 mM
136,1.1.1.169,b0425,C00797,Ethylamine,activation of enzyme from K176A mutant
137,6.3.2.10,b0086,C00797,Ethylamine,slight activation of mutant K202A
138,1.1.1.169,b0425,C00058,Formate,"E256A mutant activity greatly increased, twice as high at pH 7.2 as at pH 5.9"
139,6.3.2.10,b0086,C00058,Formate,slight activation of mutant K202A
140,1.1.1.169,b0425,C00218,Methylamine,activation of enzyme from K176A mutant
141,5.4.3.8,b0154,C00218,Methylamine,stimulates activity of mutant enzyme Lys265Arg
142,1.1.1.202,,C00116,Glycerol,
143,4.3.1.1,b4139,C00116,Glycerol,activates
144,1.1.1.336,b3787,C04501,N-Acetyl-alpha-D-glucosamine 1-phosphate,activation at low UDP-N-acetylmannosamine concentrations
145,1.1.5.3,b3426,C00016,FAD,stimulates the reaction with phenazine methosulfate and methylene blue. 20% increase in activity of the reaction with phenazine methosulfate with a half-maximal concentration of 200 nM
146,1.1.5.3,b2241,C00016,FAD,stimulates the reaction with phenazine methosulfate and methylene blue. 20% increase in activity of the reaction with phenazine methosulfate with a half-maximal concentration of 200 nM
147,1.1.5.3,b2242,C00016,FAD,stimulates the reaction with phenazine methosulfate and methylene blue. 20% increase in activity of the reaction with phenazine methosulfate with a half-maximal concentration of 200 nM
148,1.1.5.3,b2243,C00016,FAD,stimulates the reaction with phenazine methosulfate and methylene blue. 20% increase in activity of the reaction with phenazine methosulfate with a half-maximal concentration of 200 nM
149,4.1.99.3,b0708,C00016,FAD,enzyme contains FAD as catalytic cofactor and a second chromophore as a light harvesting antenna
150,4.1.99.3,b0708,C00016,FAD,FAD binding pocket is similar to that of cryptochrome 1
151,1.1.5.3,b3426,C00061,FMN,stimulates the reaction with phenazine methosulfate. 6fold increase in activity with a half-maximal concentration of 0.13 mM
152,1.1.5.3,b2241,C00061,FMN,stimulates the reaction with phenazine methosulfate. 6fold increase in activity with a half-maximal concentration of 0.13 mM
153,1.1.5.3,b2242,C00061,FMN,stimulates the reaction with phenazine methosulfate. 6fold increase in activity with a half-maximal concentration of 0.13 mM
154,1.1.5.3,b2243,C00061,FMN,stimulates the reaction with phenazine methosulfate. 6fold increase in activity with a half-maximal concentration of 0.13 mM
155,1.7.1.6,,C00061,FMN,
156,1.2.1.4,,C00469,Ethanol,0.5-2% increases activity in crude extracts
157,2.7.6.5,b2784,C00469,Ethanol,"little activity unless activated either by a complex of 70S ribosomes, mRNA and uncharged tRNA or by a solvent like ethanol at approximately 20%"
158,6.3.4.14,b3256,C00469,Ethanol,"maximal activation, 10fold, at 15% v/v. Inactivation at 20% v/v"
159,6.3.4.14,b3256,C00469,Ethanol,"maximal activation, 11fold at 15%"
160,1.2.1.21,b1415,C00250,Pyridoxal,"approx. 0.1 mM, 1.4fold increase in activity of isozyme A"
161,1.2.1.21,b1415,C00018,Pyridoxal phosphate,"approx. 0.1 mM, 1.5fold increase in activity of isozyme B"
162,2.6.1.102,,C00018,Pyridoxal phosphate,pyridoxal 5'-phosphate dependent aminotransferase
163,2.7.7.27,b3430,C00018,Pyridoxal phosphate,activation
164,2.7.7.27,b3430,C00018,Pyridoxal phosphate,activation; allosteric activator; wild-type enzyme and mutant SG14
165,2.7.7.27,b3430,C00018,Pyridoxal phosphate,
166,2.8.1.6,b0775,C00018,Pyridoxal phosphate,required for cysteine desulfurase activity of the enzyme
167,1.2.1.21,b1415,C00314,Pyridoxine,"0.1 mM, 1.5fold increase in activity of isozyme B"
168,1.2.4.2,b0726,C00008,ADP,
169,1.6.1.1,b3962,C00008,ADP,75.5% activation at 2 mM
170,2.7.1.11,b3916,C00008,ADP,
171,2.7.1.11,b1723,C00008,ADP,
172,2.7.7.27,b3430,C00008,ADP,"activation, less effective than 3-phosphoglycerate"
173,3.1.11.5,b2819,C00008,ADP,less effective than ATP
174,3.1.11.5,b2820,C00008,ADP,less effective than ATP
175,3.1.11.5,b2822,C00008,ADP,less effective than ATP
176,3.6.3.12,b0696,C00008,ADP,
177,3.6.3.12,b0697,C00008,ADP,
178,3.6.3.12,b0698,C00008,ADP,
179,4.1.1.8,b2373,C00008,ADP,"the presence of 0.3 mM ADP results in a marginal increase in kcat and a small decrease in Km, leading to a 1.7fold higher catalytic efficiency. One molecule of ADP is bound per monomer distant from the CoA binding site"
180,1.2.4.2,b0726,C00009,Orthophosphate,
181,1.8.1.9,b0888,C00009,Orthophosphate,2fold activation
182,2.3.1.41,b2323,C00009,Orthophosphate,"activation, 0.2 M"
183,2.7.4.1,b2501,C00009,Orthophosphate,"inhibiton above 20 mM; required for activity, only in the presence of histone"
184,2.7.7.8,b3164,C00009,Orthophosphate,"1-10 mM, strong activation of PNPase exonuclease activity"
185,2.7.7.8,b3164,C00009,Orthophosphate,
186,3.1.11.6,b0422,C00009,Orthophosphate,5-10fold higher activity compared to Tris-HCL buffer
187,3.1.11.6,b2509,C00009,Orthophosphate,5-10fold higher activity compared to Tris-HCL buffer
188,3.1.11.6,b0422,C00009,Orthophosphate,stimulates
189,3.1.11.6,b2509,C00009,Orthophosphate,stimulates
190,3.5.1.16,b3957,C00009,Orthophosphate,
191,1.2.5.1,b0871,C08365,Ricinoleic acid,119% of the activitation with palmitic acid
192,1.2.5.1,b0871,C01712,(9E)-Octadecenoic acid,122% of the activitation with palmitic acid
193,1.2.5.1,b0871,C02679,Dodecanoic acid,126% of the activitation with palmitic acid
194,1.2.5.1,b0871,C02679,Dodecanoic acid,"activation by covalent attachment, binding site Lys544"
195,1.2.5.1,b0871,C01595,Linoleate,116% of the activitation with palmitic acid
196,1.2.5.1,b0871,C01595,Linoleate,113% of the activitation with palmitic acid
197,1.2.5.1,b0871,C06427,"(9Z,12Z,15Z)-Octadecatrienoic acid",126% of the activitation with palmitic acid
198,1.2.5.1,b0871,C06424,Tetradecanoic acid,109% of the activitation with palmitic acid
199,1.2.5.1,b0871,C01601,Nonanoic acid,42% of the activitation with palmitic acid
200,1.2.5.1,b0871,C00712,(9Z)-Octadecenoic acid,
201,1.2.5.1,b0871,C00712,(9Z)-Octadecenoic acid,102% of the activitation with palmitic acid
202,2.7.1.107,b4042,C00712,(9Z)-Octadecenoic acid,activates only in presence of Triton X-100
203,1.2.5.1,b0871,C00249,Hexadecanoic acid,
204,1.2.5.1,b0871,C00249,Hexadecanoic acid,activation
205,2.7.1.107,b4042,C00249,Hexadecanoic acid,activates only in presence of Triton X-100
206,1.2.5.1,b0871,C08362,(9Z)-Hexadecenoic acid,137% of the activitation with palmitic acid
207,1.3.3.11,,C00005,NADPH,NAD(P)H enhances pyrroloquinoline quinone production in the presence of activating factor ActF
208,5.4.99.9,b2036,C00005,NADPH,"enzyme activation mechanism, overview"
209,1.3.5.1,b0723,C00002,ATP,activation
210,1.3.5.1,b0724,C00002,ATP,activation
211,1.3.5.1,b0723,C00002,ATP,
212,1.3.5.1,b0724,C00002,ATP,
213,1.4.1.4,b1761,C00002,ATP,"at 2 mM, 50% activation"
214,1.6.1.1,b3962,C00002,ATP,53.4% activation at 2 mM
215,1.17.4.1,b2675,C00002,ATP,stimulation of CDP reduction; stimulation of UDP reduction
216,1.17.4.1,b2676,C00002,ATP,stimulation of CDP reduction; stimulation of UDP reduction
217,1.17.4.1,b2234,C00002,ATP,stimulation of CDP reduction; stimulation of UDP reduction
218,1.17.4.1,b2235,C00002,ATP,stimulation of CDP reduction; stimulation of UDP reduction
219,1.17.4.1,b2675,C00002,ATP,ATP is an allosteric effector
220,1.17.4.1,b2676,C00002,ATP,ATP is an allosteric effector
221,1.17.4.1,b2234,C00002,ATP,ATP is an allosteric effector
222,1.17.4.1,b2235,C00002,ATP,ATP is an allosteric effector
223,1.17.4.1,b2675,C00002,ATP,
224,1.17.4.1,b2676,C00002,ATP,
225,1.17.4.1,b2234,C00002,ATP,
226,1.17.4.1,b2235,C00002,ATP,
227,1.17.4.1,b2675,C00002,ATP,activation by ATP has a regulatory function
228,1.17.4.1,b2676,C00002,ATP,activation by ATP has a regulatory function
229,1.17.4.1,b2234,C00002,ATP,activation by ATP has a regulatory function
230,1.17.4.1,b2235,C00002,ATP,activation by ATP has a regulatory function
231,2.1.3.2,b4245,C00002,ATP,
232,2.1.3.2,b4245,C00002,ATP,"allosteric effector, increases the apparent rate of unliganded T-state to substrate-bound R-state"
233,2.1.3.2,b4245,C00002,ATP,"ATP enhances ATCase activity. Experimentally driven, statistical modeling approach (high-dimensional model representation, RS-HDMR) to investigate regulation of ATCase in response to varying concentrations of its nucleotide regulators ATP, CTP, GTP, and UTP (at fixed substrate concentrations)"
234,2.1.3.2,b4245,C00002,ATP,addition of ATP along with the substrates increases the rate of the transition from the low activity T to the high activity R state and also decreases the duration of the R-state steady-state phase
235,2.1.3.2,b4245,C00002,ATP,"the effects of binding of nucleotides are monitored in a series of 1H-13C methyl TROSY spectroscopy spectra recorded on the 300 kDa aspartate transcarbamoylase holoenzyme in both the absence and the presence of saturating amounts of ATP or CTP. No changes in shifts of methyl probes of the catalytic chains that include the active sites are observed, consistent with a lack of structural changes. Results indicate that the mechanism of action of ATP and CTP can be explained fully by the Monod-Wyman-Changeux model"
236,2.3.1.15,b4041,C00002,ATP,activation of acyltransferase in isolated membrane preparations
237,2.3.1.15,b1090,C00002,ATP,activation of acyltransferase in isolated membrane preparations
238,2.3.1.15,b3059,C00002,ATP,activation of acyltransferase in isolated membrane preparations
239,2.7.1.89,b1106,C00002,ATP,dependent on the presence of
240,2.7.7.41,b0175,C00002,ATP,a maximal stimulation of about 3fold with CTP as substrate and 1.25fold with dCTP
241,2.7.7.41,b1409,C00002,ATP,a maximal stimulation of about 3fold with CTP as substrate and 1.25fold with dCTP
242,3.1.3.41,,C00002,ATP,"stimulates the 4-nitrophenyl phosphatase activity 3.5fold at concentrations of 0.001-0.030 mM, but inhibits it at concentrations above 0.5 mM, mechanism"
243,3.1.21.5,,C00002,ATP,"ATP hydrolysis activated by recognition site binding leads to release of the enzyme from the site, dissociation from the substrate via a free DNA end and cleavage of the DNA"
244,3.1.21.7,b3998,C00002,ATP,required
245,3.2.2.4,b1982,C00002,ATP,
246,3.4.24.B17,,C00002,ATP,ATP-dependent metalloendoprotease belonging to the AAA family (ATPases associated with diverse cellular activities)
247,3.4.24.B20,,C00002,ATP,dependent on
248,3.4.24.B20,,C00002,ATP,"dependent on, the C-terminus comprise the cytoplasmic ATPase and protease domain. The ATPase domain contains the Walker A/B motifs and the second region of homology responsible for the binding and hydrolysis of ATP"
249,3.6.1.1,b4226,C00002,ATP,"ATP activates hydrolysis of MgPPi by E-PPase, molecular docking and kinetic analysis involving Lys112 and Lys115, activation mechanism, and regulatory function of ATP, modelling, overview"
250,3.6.3.1,,C00002,ATP,"flippase activity is essentially supported only by ATP. If the ATP concentration in the assay falls below 5 mM, there is a significant decrease in flippase activity. Maximal translocation occurs at 10 mM ATP"
251,3.6.3.12,b0696,C00002,ATP,
252,3.6.3.12,b0697,C00002,ATP,
253,3.6.3.12,b0698,C00002,ATP,
254,3.6.4.10,,C00002,ATP,"in 1:1 mixture with ATP-gammaS, greatly stimulates protein remodeling"
255,4.1.1.8,b2373,C00002,ATP,weak activating effect
256,4.2.1.30,,C00002,ATP,
257,1.3.5.1,b0723,C00013,Diphosphate,activation
258,1.3.5.1,b0724,C00013,Diphosphate,activation
259,2.7.4.1,b2501,C00013,Diphosphate,"10 mM, 100% activation of guanosine 5'-tetraphosphate synthesis"
260,2.7.7.8,b3164,C00013,Diphosphate,activation of PNPase RNA synthesis activity at very low concentrations of phosphate
261,1.3.5.1,b0723,C13199,Sodium sulfate,activation
262,1.3.5.1,b0724,C13199,Sodium sulfate,activation
263,2.4.1.1,b3417,C13199,Sodium sulfate,activation
264,2.4.1.1,b3428,C13199,Sodium sulfate,activation
265,1.4.1.4,b1761,C00020,AMP,slight activation up to 1 mM
266,1.6.1.1,b3962,C00020,AMP,71.8% activation at 2 mM
267,2.7.7.27,b3430,C00020,AMP,"activation, less effective than 3-phosphoglycerate"
268,2.7.7.27,b3430,C00020,AMP,
269,4.1.1.8,b2373,C00020,AMP,weak activating effect
270,1.4.1.4,b1761,C00075,UTP,activates up to 70%
271,2.1.3.2,b4245,C00075,UTP,"allosteric effector, makes steady state vanishingly short"
272,3.1.11.5,b2819,C00075,UTP,less effective than ATP
273,3.1.11.5,b2820,C00075,UTP,less effective than ATP
274,3.1.11.5,b2822,C00075,UTP,less effective than ATP
275,1.4.3.16,b2574,C00049,L-Aspartate,substrate activation above 1.0 mM
276,4.3.1.1,b4139,C00049,L-Aspartate,activates the fumarate-amination reaction
277,1.5.1.30,,C00004,NADH,
278,1.17.1.8,b0031,C00004,NADH,
279,1.5.1.30,,C00005,NADPH,
280,1.17.1.8,b0031,C00005,NADPH,similar affinity as NADH
281,2.7.7.27,b3430,C00005,NADPH,activation; no activation
282,2.8.1.10,b3991,C00005,NADPH,strong stimulation
283,4.2.1.47,b2053,C00005,NADPH,activates
284,1.7.1.6,,C00090,Catechol,"6 mM, increase in expression of azoR mRNA relative to the expression at zero time before stress is applied, at 10 min 15.6, at 20 min 31.9"
285,1.7.1.6,,C05377,Menadione,"0.3 mM, increase in expression of azoR mRNA relative to the expression at zero time before stress is applied, at 10 min 25.5, at 20 min 13.3"
286,1.7.2.2,b4070,C00076,Calcium cation,
287,2.4.1.227,b0090,C00076,Calcium cation,
288,1.7.99.1,b0873,C01326,Hydrogen cyanide,stimulates at concentrations above 5 mM
289,1.7.99.4,b2206,C00324,Ferricyanide,"enzyme as prepared is slowly activated at pH 7.2 over 250% of the original activity, dependent on ferricyanide concentration, little activation at pH 9.5"
290,1.7.99.4,b1227,C00324,Ferricyanide,"enzyme as prepared is slowly activated at pH 7.2 over 250% of the original activity, dependent on ferricyanide concentration, little activation at pH 9.5"
291,1.7.99.4,b1224,C00324,Ferricyanide,"enzyme as prepared is slowly activated at pH 7.2 over 250% of the original activity, dependent on ferricyanide concentration, little activation at pH 9.5"
292,1.7.99.4,b1225,C00324,Ferricyanide,"enzyme as prepared is slowly activated at pH 7.2 over 250% of the original activity, dependent on ferricyanide concentration, little activation at pH 9.5"
293,1.7.99.4,b1467,C00324,Ferricyanide,"enzyme as prepared is slowly activated at pH 7.2 over 250% of the original activity, dependent on ferricyanide concentration, little activation at pH 9.5"
294,1.7.99.4,b1465,C00324,Ferricyanide,"enzyme as prepared is slowly activated at pH 7.2 over 250% of the original activity, dependent on ferricyanide concentration, little activation at pH 9.5"
295,1.7.99.4,b1468,C00324,Ferricyanide,"enzyme as prepared is slowly activated at pH 7.2 over 250% of the original activity, dependent on ferricyanide concentration, little activation at pH 9.5"
296,1.11.1.6,b1732,C10937,Bensulfuron-methyl,
297,1.11.1.6,b1732,C01589,Imidazole,2fold activation at 10 mM
298,1.11.1.6,b1732,C18806,Quinclorac,
299,1.14.11.17,b0368,C00072,Ascorbate,50% increase in activity at 0.2-0.8 mM
300,1.14.11.46,,C00072,Ascorbate,required
301,2.7.1.25,b2750,C00072,Ascorbate,activation
302,1.14.12.17,b2552,C00032,Heme,maximal activity at 0.001 mM
303,1.14.13.59,,C00077,L-Ornithine,"stimulates, but remains unchanged"
304,1.17.4.1,b2675,C00131,dATP,stimulation of CDP and UDP reduction
305,1.17.4.1,b2676,C00131,dATP,stimulation of CDP and UDP reduction
306,1.17.4.1,b2234,C00131,dATP,stimulation of CDP and UDP reduction
307,1.17.4.1,b2235,C00131,dATP,stimulation of CDP and UDP reduction
308,1.17.4.1,b2675,C00131,dATP,
309,1.17.4.1,b2676,C00131,dATP,
310,1.17.4.1,b2234,C00131,dATP,
311,1.17.4.1,b2235,C00131,dATP,
312,3.1.11.5,b2819,C00131,dATP,nearly as effective as ATP
313,3.1.11.5,b2820,C00131,dATP,nearly as effective as ATP
314,3.1.11.5,b2822,C00131,dATP,nearly as effective as ATP
315,1.17.4.1,b2675,C00458,dCTP,stimulation of UDP reduction
316,1.17.4.1,b2676,C00458,dCTP,stimulation of UDP reduction
317,1.17.4.1,b2234,C00458,dCTP,stimulation of UDP reduction
318,1.17.4.1,b2235,C00458,dCTP,stimulation of UDP reduction
319,2.7.1.21,b1238,C00458,dCTP,activation
320,3.1.11.5,b2819,C00458,dCTP,less effective than ATP
321,3.1.11.5,b2820,C00458,dCTP,less effective than ATP
322,3.1.11.5,b2822,C00458,dCTP,less effective than ATP
323,1.17.4.1,b2675,C00286,dGTP,stimulation of ADP reduction; stimulation of GDP reduction
324,1.17.4.1,b2676,C00286,dGTP,stimulation of ADP reduction; stimulation of GDP reduction
325,1.17.4.1,b2234,C00286,dGTP,stimulation of ADP reduction; stimulation of GDP reduction
326,1.17.4.1,b2235,C00286,dGTP,stimulation of ADP reduction; stimulation of GDP reduction
327,1.17.4.1,b2675,C00286,dGTP,stimulation of ADP reduction; stimulation of tubercidin diphosphate reduction
328,1.17.4.1,b2676,C00286,dGTP,stimulation of ADP reduction; stimulation of tubercidin diphosphate reduction
329,1.17.4.1,b2234,C00286,dGTP,stimulation of ADP reduction; stimulation of tubercidin diphosphate reduction
330,1.17.4.1,b2235,C00286,dGTP,stimulation of ADP reduction; stimulation of tubercidin diphosphate reduction
331,1.17.4.1,b2675,C00286,dGTP,stimulation of ADP reduction
332,1.17.4.1,b2676,C00286,dGTP,stimulation of ADP reduction
333,1.17.4.1,b2234,C00286,dGTP,stimulation of ADP reduction
334,1.17.4.1,b2235,C00286,dGTP,stimulation of ADP reduction
335,1.17.4.1,b2675,C00286,dGTP,
336,1.17.4.1,b2676,C00286,dGTP,
337,1.17.4.1,b2234,C00286,dGTP,
338,1.17.4.1,b2235,C00286,dGTP,
339,2.7.4.22,b0171,C00286,dGTP,lower affinity or extent of activation than GTP
340,2.7.4.22,b0171,C00286,dGTP,
341,1.17.99.6,b4166,C00853,Cob(I)alamin,stimulates
342,1.20.4.1,b3503,C00051,Glutathione,required
343,1.20.4.1,b2495,C00051,Glutathione,required
344,1.20.4.1,b3503,C00051,Glutathione,glutathione is not effective as electron donor
345,1.20.4.1,b2495,C00051,Glutathione,glutathione is not effective as electron donor
346,1.20.4.1,b3503,C00051,Glutathione,the enzyme uses GSH with glutaredoxin as electron donor
347,1.20.4.1,b2495,C00051,Glutathione,the enzyme uses GSH with glutaredoxin as electron donor
348,2.7.7.38,b0918,C00051,Glutathione,
349,6.3.4.21,b0931,C00051,Glutathione,activation
350,2.1.1.13,b4019,C01330,Sodium cation,at 67 mM 1.5 fold activity
351,2.1.1.13,b4019,C00019,S-Adenosyl-L-methionine,required
352,2.8.1.6,b0775,C00019,S-Adenosyl-L-methionine,"two molecules of S-adenosyl-L-methionine are used to synthesize one molecule of biotin, one from dethiobiotin to the intermediate, and a second from the intermediate to biotin"
353,2.8.1.6,b0775,C00019,S-Adenosyl-L-methionine,required
354,2.8.1.6,b0775,C00019,S-Adenosyl-L-methionine,one molecule S-adenosyl-L-methionine is required to form one molecule of biotin
355,2.8.1.6,b0775,C00019,S-Adenosyl-L-methionine,
356,3.1.21.3,b4348,C00019,S-Adenosyl-L-methionine,"stimulates, not required"
357,3.1.21.3,b4350,C00019,S-Adenosyl-L-methionine,"stimulates, not required"
358,3.1.21.3,b4348,C00019,S-Adenosyl-L-methionine,required
359,3.1.21.3,b4350,C00019,S-Adenosyl-L-methionine,required
360,3.1.21.3,b4348,C00019,S-Adenosyl-L-methionine,
361,3.1.21.3,b4350,C00019,S-Adenosyl-L-methionine,
362,2.1.1.13,b4019,C00019,S-Adenosyl-L-methionine,at about 0.0001 mM
363,2.3.1.54,b0903,C00019,S-Adenosyl-L-methionine,
364,2.3.1.54,b3114,C00019,S-Adenosyl-L-methionine,
365,2.3.1.54,b0823,C00019,S-Adenosyl-L-methionine,
366,2.3.1.54,b3951,C00019,S-Adenosyl-L-methionine,
367,2.3.1.54,b0903,C00019,S-Adenosyl-L-methionine,obligatory component of the activation reaction
368,2.3.1.54,b3114,C00019,S-Adenosyl-L-methionine,obligatory component of the activation reaction
369,2.3.1.54,b0823,C00019,S-Adenosyl-L-methionine,obligatory component of the activation reaction
370,2.3.1.54,b3951,C00019,S-Adenosyl-L-methionine,obligatory component of the activation reaction
371,2.5.1.6,b2942,C00019,S-Adenosyl-L-methionine,enhances tripolyphosphatase activity
372,2.8.1.10,b3991,C00019,S-Adenosyl-L-methionine,strong stimulation
373,3.1.11.5,b2819,C00019,S-Adenosyl-L-methionine,less effective than ATP
374,3.1.11.5,b2820,C00019,S-Adenosyl-L-methionine,less effective than ATP
375,3.1.11.5,b2822,C00019,S-Adenosyl-L-methionine,less effective than ATP
376,2.1.1.35,b3965,C00134,Putrescine,"activates, inhibitory at optimal Mg2+ concentration"
377,3.1.13.1,b1286,C00134,Putrescine,can replace missing Mg2+ to a small extent
378,2.1.1.35,b3965,C00750,Spermine,slight activation
379,2.7.7.8,b3164,C00750,Spermine,"0.1-1.0 mM, activates ADP-phosphate exchange 2fold"
380,3.1.13.1,b1286,C00750,Spermine,can replace missing Mg2+ to a small extent
381,3.1.26.5,b3704,C00750,Spermine,M1 RNA subunit can catalyze the cleavage of tRNA precursor molecules in the presence of 5 mM spermine or spermidine
382,3.2.2.21,b2068,C00750,Spermine,stimulates activity
383,6.1.1.18,b0680,C00750,Spermine,"significant stimulation of ATP-diphosphate exchange and aminoacylation in presence of limited MgCl2 concentrations, cannot totally replace Mg2+"
384,6.1.1.19,b1876,C00750,Spermine,supports aminoacylation in presence of crude tRNA not in presence of resolved tRNA
385,2.1.1.45,b2827,C02924,Dimercaprol,"absolute requirement for a thiol, synthetase shows greatly dimished activity in absence"
386,2.1.1.79,b1661,C01353,Carbonic acid,required. CFA synthase isolated and assayed in potassium bicarbonate buffer displayes more than 3-fold higher activity than in HEPES buffer
387,3.4.11.10,,C01353,Carbonic acid,activates
388,4.2.1.104,b0340,C01353,Carbonic acid,
389,2.1.3.2,b4245,C00212,Adenosine,very weak activation
390,2.7.7.89,,C00212,Adenosine,"activation by nucleotides, most efficient in presence of two different nucleotides"
391,3.1.11.5,b2819,C00212,Adenosine,less effective than ATP
392,3.1.11.5,b2820,C00212,Adenosine,less effective than ATP
393,3.1.11.5,b2822,C00212,Adenosine,less effective than ATP
394,2.1.3.2,b4245,C00149,(S)-Malate,activation in presence of excess carbamoyl phosphate and limiting L-aspartate
395,2.1.3.2,b4245,C00552,meso-Tartaric acid,activation in presence of excess carbamoyl phosphate and limiting L-aspartate
396,2.1.3.2,b4245,C00042,Succinate,activation in presence of excess carbamoyl phosphate and limiting L-aspartate
397,3.1.3.2,b4055,C00042,Succinate,stimulates
398,3.1.3.2,b0980,C00042,Succinate,stimulates
399,3.4.24.B17,,C00042,Succinate,"stimulates, antagonist of carbonyl cyanide-3-chlorophenylhydrazone"
400,2.3.1.8,b2297,C00022,Pyruvate,
401,2.3.1.8,b2297,C00022,Pyruvate,156% of activation at 5 mM
402,2.3.1.54,b0903,C00022,Pyruvate,obligatory component of the activation reaction
403,2.3.1.54,b3114,C00022,Pyruvate,obligatory component of the activation reaction
404,2.3.1.54,b0823,C00022,Pyruvate,obligatory component of the activation reaction
405,2.3.1.54,b3951,C00022,Pyruvate,obligatory component of the activation reaction
406,2.7.7.27,b3430,C00022,Pyruvate,activation of chimeric enzyme EA contains the N-terminus of Escherichia coli enzyme and the C-terminus of Agrobacterium tumefaciens enzyme with higher affinity than activation of chimeric enzyme AE contains the N-terminus of Agrobacterium tumefaciens enzyme and the C-terminus of Escherichia coli enzyme
407,2.8.1.7,b2530,C00022,Pyruvate,"increases activity of CSD towards L-selenocysteine, but not towards L-cysteine"
408,2.8.1.7,b1680,C00022,Pyruvate,"increases activity of CSD towards L-selenocysteine, but not towards L-cysteine"
409,3.1.3.2,b4055,C00022,Pyruvate,stimulates
410,3.1.3.2,b0980,C00022,Pyruvate,stimulates
411,4.1.1.50,b0120,C00022,Pyruvate,contains pyruvate
412,4.1.1.50,b0120,C00022,Pyruvate,cofactor; contains 1 pyruvoyl residue for each alphabeta pair
413,4.1.1.50,b0120,C00022,Pyruvate,each subunit contains one covalently linked pyruvate
414,4.1.1.65,b4160,C00022,Pyruvate,dependent on
415,4.1.1.65,b4160,C00022,Pyruvate,the small subunit contains a pyruvoyl prosthetic group
416,4.1.1.65,b4160,C00022,Pyruvate,the pyruvoyl residue is covalently bound to the amino terminus of one of the two nonidentical subunits
417,4.1.1.65,b4160,C00022,Pyruvate,dependent on; the pyruvate prosthetic group is in amide linkage to the amino terminus of the alpha-subunit. The prosthetic group is derived from Ser through a post-tranlational cleavage of a proenzyme
418,4.4.1.16,b1680,C00022,Pyruvate,
419,2.3.1.54,b0903,C01444,Oxamate,
420,2.3.1.54,b3114,C01444,Oxamate,
421,2.3.1.54,b0823,C01444,Oxamate,
422,2.3.1.54,b3951,C01444,Oxamate,
423,2.3.1.54,b0903,C01444,Oxamate,obligatory component of the activation reaction
424,2.3.1.54,b3114,C01444,Oxamate,obligatory component of the activation reaction
425,2.3.1.54,b0823,C01444,Oxamate,obligatory component of the activation reaction
426,2.3.1.54,b3951,C01444,Oxamate,obligatory component of the activation reaction
427,2.3.1.181,b0630,C18606,Potassium bicarbonate,"100 mM, slight activation"
428,2.3.2.12,,C00132,Methanol,optimal concentration: 45-50%
429,4.1.1.98,b3843,C00132,Methanol,strong stimulation
430,2.3.2.12,,C03413,"N1,N12-Diacetylspermine","both stimulatory and inhibitory effects at the kinetic phase in the presence of the factors washable from ribosomes, depending on ligand concentration"
431,2.3.2.12,,C02567,N1-Acetylspermine,"both stimulatory and inhibitory effects at the kinetic phase in the presence of the factors washable from ribosomes, depending on ligand concentration"
432,2.4.1.1,b3417,C00020,AMP,activation; in both directions
433,2.4.1.1,b3428,C00020,AMP,activation; in both directions
434,3.1.11.5,b2819,C00020,AMP,less effective than ATP
435,3.1.11.5,b2820,C00020,AMP,less effective than ATP
436,3.1.11.5,b2822,C00020,AMP,less effective than ATP
437,2.4.1.21,b3429,C08142,Sodium fluoride,"500 mM, strong activation of unprimed reaction"
438,2.4.1.21,b3429,C12554,Potassium acetate,"500 mM, strong activation of unprimed reaction"
439,2.7.7.6,b3987,C12554,Potassium acetate,activates
440,2.7.7.6,b3988,C12554,Potassium acetate,activates
441,2.7.7.6,b3295,C12554,Potassium acetate,activates
442,2.7.7.6,b3649,C12554,Potassium acetate,activates
443,2.4.1.129,b0149,C05551,Penicillin G,"stimulation, in the presence of 15% methanol, not at higher methanol concentrations or in the presence of deoxycholate"
444,2.4.1.129,b0149,C11143,Dimethyl sulfoxide,"activation, in the absence of methanol, inhibits in the presence of 0.05% sarkosyl"
445,3.4.21.53,b0439,C11143,Dimethyl sulfoxide,activation
446,4.3.1.1,b4139,C11143,Dimethyl sulfoxide,activates
447,2.4.1.129,b0149,C06665,Imipenem,"stimulation, in the presence of 15% methanol, not at higher methanol concentrations or in the presence of deoxycholate"
448,2.4.1.227,b0090,C11143,Dimethyl sulfoxide,
449,2.4.1.227,b0090,C11143,Dimethyl sulfoxide,high concentration (35%) of dimethylsulfoxide is necessary for maximal enzyme activity
450,2.4.1.227,b0090,C00305,Magnesium cation,
451,2.7.1.73,b0477,C00305,Magnesium cation,enzyme requires both Mg2+ and K+
452,3.1.3.1,b0383,C00305,Magnesium cation,
453,3.1.27.10,,C00305,Magnesium cation,strong decrease of efficiency of oligonucleotide hybridization
454,2.4.2.8,b0125,C00033,Acetate,slightly activating
455,3.1.3.2,b4055,C00033,Acetate,stimulates
456,3.1.3.2,b0980,C00033,Acetate,stimulates
457,6.3.2.10,b0086,C00033,Acetate,activation of mutant K202A
458,2.4.2.9,b2498,C00044,GTP,"effect is pH-dependent, pH 7.5: lowers Km value for 5-phospho-alpha-D-ribose 1-diphosphate and increases Vmax 2fold, no effect on Km for uracil, pH 8.0: no effect"
459,2.4.2.9,b2498,C00044,GTP,"about 5-7fold increase of Km for 5-phosphoribose 1-diphosphate, unaltered Vmax; highly activating at low 5-phosphoribose 1-diphosphate concentration, e.g. 0.2 mM, by modification of the structure from dimer/trimer to pentamer/hexamer; kinetics"
460,2.4.2.9,b2498,C00044,GTP,"activation of wild-type and mutant P131D, maximal at 0.08 mM"
461,2.7.1.21,b1238,C00044,GTP,activation
462,2.7.4.22,b0171,C00044,GTP,"activates only the wild-type, not the mutant D201N"
463,2.7.4.22,b0171,C00044,GTP,most effective at pH 8 and a high (1 mM) UMP concentration
464,2.7.4.22,b0171,C00044,GTP,"0.5 mM, reverses the inhibition of excess UMP, it increases the affinity for ATP"
465,2.7.4.22,b0171,C00044,GTP,"; allosteric activator, the GTP-binding site, situated at 15 A from the UMP-binding site and at 24 A from the ATP-binding site, is delineated by two contiguous dimers. movements induced by binding GTP, overview. UTP and GTP are tightly coupled in both wild-type enzyme and N140A variant"
466,2.7.4.22,b0171,C00044,GTP,
467,2.7.7.89,,C00044,GTP,"activation by nucleotides, most efficient in presence of two different nucleotides"
468,3.1.11.5,b2819,C00044,GTP,less effective than ATP
469,3.1.11.5,b2820,C00044,GTP,less effective than ATP
470,3.1.11.5,b2822,C00044,GTP,less effective than ATP
471,3.4.21.53,b0439,C00044,GTP,"activation; hydrolysis at 113% the rate of ATP, supports proteolysis with 14% the efficiency of ATP"
472,3.4.21.53,b0439,C00044,GTP,not
473,3.4.21.53,b0439,C00044,GTP,activation; less efficient than ATP
474,3.6.5.4,b2610,C00044,GTP,GTP binding to both the SRP and SR is a prerequisite for the formation of the SRP-SR complex in which GTP hydrolysis is activated in a composite active site
475,4.1.1.31,b3956,C00044,GTP,activates
476,6.3.4.2,b2780,C00044,GTP,required as an allosteric effector to promote glutamine hydrolysis
477,6.3.4.2,b2780,C00044,GTP,"required as allosteric effector to promote reaction with glutamine as substrate, GTP functions by stabilizing the protein conformation that binds the tetrahedral intermediate(s) formed during glutamine hydrolysis"
478,6.3.4.2,b2780,C00044,GTP,activates enzyme-catalyzed glutamine hydrolysis
479,6.3.4.2,b2780,C00044,GTP,"0.1 mM guanosine, kact: 10.3/sec, KA: 0.088 mM, Ki: 0.22 mM; 0.2 mM guanosine, kact: 8.2/sec, KA: 0.078 mM, Ki: 0.12 mM; 0 mM guanosine, kact: 10.6/sec, KA: 0.081 mM, Ki: 0.28 mM; allosteric effector, structural requirements for activation are stringent, but requirements for inhibition are lax. GTP promotes Gln hydrolysis but inhibits Gln-dependent CTP formation at concentrations of over 0.15 mM"
480,6.3.4.2,b2780,C00044,GTP,"required, activates"
481,6.3.4.2,b2780,C00044,GTP,"GTP acts a positive allosteric effector for Gln-dependent CTP formation. However, at concentrations exceeding 0.15 mM, GTP inhibits Gln-dependent CTP formation. Moreover, GTP is an inhibitor of NH3-dependent CTP formation at all concentrations"
482,6.3.5.5,b0032,C00044,GTP,enhances activity
483,6.3.5.5,b0033,C00044,GTP,enhances activity
484,2.4.2.14,b2312,C00119,5-Phospho-alpha-D-ribose 1-diphosphate,3-4fold activation of glutaminase activity in the presence of phosphate or diphosphate
485,2.4.99.17,b0405,C01353,Carbonic acid,100% activity in the presence of 25 mM carbonate
486,2.5.1.39,b4040,C11321,3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate,46% increase at 0.01%
487,3.1.4.14,b0404,C11321,3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate,
488,2.6.1.85,b3360,C00568,4-Aminobenzoate,
489,2.6.1.85,b1812,C00568,4-Aminobenzoate,
490,2.7.1.11,b3916,C00035,GDP,activation
491,2.7.1.11,b1723,C00035,GDP,activation
492,2.7.1.11,b3916,C00035,GDP,
493,2.7.1.11,b1723,C00035,GDP,
494,2.7.1.21,b1238,C00705,dCDP,activation
495,2.7.1.40,b1676,C05378,"beta-D-Fructose 1,6-bisphosphate","heterotropic activator of PK1, the modulation of oligomeric state by the allosteric effector D-fructose 1,6-bisphosphate does not occur at a concentration of 10 nM or above"
496,2.7.1.40,b1854,C05378,"beta-D-Fructose 1,6-bisphosphate","heterotropic activator of PK1, the modulation of oligomeric state by the allosteric effector D-fructose 1,6-bisphosphate does not occur at a concentration of 10 nM or above"
497,2.7.7.27,b3430,C05378,"beta-D-Fructose 1,6-bisphosphate",allosteric activator
498,2.7.7.27,b3430,C05378,"beta-D-Fructose 1,6-bisphosphate",allosteric activator; most important in vivo
499,2.7.7.27,b3430,C05378,"beta-D-Fructose 1,6-bisphosphate","mainly Escherichia coli and chimeric enzyme AE containing the N-terminus of Agrobacterium tumefaciens enzyme and the C-terminus of Escherichia coli enzyme, not chimeric enzyme EA containing the N-terminus of Escherichia coli enzyme and the C-terminus of Agrobacterium tumefaciens enzyme, C-terminus of Escherichia coli is relavant for the selectivity"
500,2.7.7.27,b3430,C05378,"beta-D-Fructose 1,6-bisphosphate",
501,2.7.7.27,b3430,C05378,"beta-D-Fructose 1,6-bisphosphate","50% activation at 0.0364 mM for wild-type, at 0.0523 mM for mutant lacking N-terminal 3 amino acids, at 0.0887 mM for mutant lacking N-terminal 7 amino acids"
502,2.7.1.40,b1676,C05378,"beta-D-Fructose 1,6-bisphosphate",activation
503,2.7.1.40,b1854,C05378,"beta-D-Fructose 1,6-bisphosphate",activation
504,2.7.7.27,b3430,C05378,"beta-D-Fructose 1,6-bisphosphate",50% of maximal activation at 0.059 for wild-type
505,2.7.1.40,b1676,C00092,D-Glucose 6-phosphate,isozyme PK II
506,2.7.1.40,b1854,C00092,D-Glucose 6-phosphate,isozyme PK II
507,2.7.7.27,b3430,C00092,D-Glucose 6-phosphate,activation
508,2.7.7.27,b3430,C00092,D-Glucose 6-phosphate,
509,2.7.1.40,b1676,C00117,D-Ribose 5-phosphate,activation; isozyme PK II
510,2.7.1.40,b1854,C00117,D-Ribose 5-phosphate,activation; isozyme PK II
511,2.7.1.40,b1676,C00117,D-Ribose 5-phosphate,
512,2.7.1.40,b1854,C00117,D-Ribose 5-phosphate,
513,2.7.7.27,b3430,C00117,D-Ribose 5-phosphate,D-fructose 6-phosphate analog
514,2.7.1.40,b1676,C00074,Phosphoenolpyruvate,"homotropic activator of PK1, the modulation of oligomeric state by the allosteric effector phosphoenolpyruvate does not occur at a concentration of 10 nM or above"
515,2.7.1.40,b1854,C00074,Phosphoenolpyruvate,"homotropic activator of PK1, the modulation of oligomeric state by the allosteric effector phosphoenolpyruvate does not occur at a concentration of 10 nM or above"
516,2.7.3.9,b2416,C00074,Phosphoenolpyruvate,"physiological concentrations of phosphoenolpyruvate and Mg2+ increase the amount of dimeric, active dephospho-enzyme I"
517,2.7.3.9,b2829,C00074,Phosphoenolpyruvate,"physiological concentrations of phosphoenolpyruvate and Mg2+ increase the amount of dimeric, active dephospho-enzyme I"
518,2.7.3.9,b3947,C00074,Phosphoenolpyruvate,"physiological concentrations of phosphoenolpyruvate and Mg2+ increase the amount of dimeric, active dephospho-enzyme I"
519,2.7.3.9,b2383,C00074,Phosphoenolpyruvate,"physiological concentrations of phosphoenolpyruvate and Mg2+ increase the amount of dimeric, active dephospho-enzyme I"
520,2.7.7.27,b3430,C00074,Phosphoenolpyruvate,activation; less effective than fructose bisphosphate
521,2.7.7.27,b3430,C00074,Phosphoenolpyruvate,
522,3.1.3.11,b3925,C00074,Phosphoenolpyruvate,
523,3.1.3.11,b4232,C00074,Phosphoenolpyruvate,
524,3.1.3.11,b3925,C00074,Phosphoenolpyruvate,up to 300% activation
525,3.1.3.11,b4232,C00074,Phosphoenolpyruvate,up to 300% activation
526,3.1.3.11,b3925,C00074,Phosphoenolpyruvate,activates
527,3.1.3.11,b4232,C00074,Phosphoenolpyruvate,activates
528,4.1.2.13,b2925,C00074,Phosphoenolpyruvate,"enhances D-fructose 1,6-bisphosphate-cleavage activity, fructose 1-phosphate-cleavage activity is unaffected"
529,4.1.2.13,b2097,C00074,Phosphoenolpyruvate,"enhances D-fructose 1,6-bisphosphate-cleavage activity, fructose 1-phosphate-cleavage activity is unaffected"
530,2.7.1.107,b4042,C00823,1-Hexadecanol,activates
531,2.7.1.107,b4042,C11166,SDS,activates
532,3.5.1.28,b2435,C11166,SDS,
533,3.5.1.28,b4169,C11166,SDS,
534,3.5.1.28,b2817,C11166,SDS,
535,3.5.1.28,b0867,C11166,SDS,
536,2.7.1.107,b4042,C01530,Octadecanoic acid,activates only in presence of Triton X-100
537,2.7.1.136,,C01912,Erythromycin,crude cell extracts from cells treated with erythromycin show increased activity
538,3.1.26.5,b3704,C01912,Erythromycin,
539,2.7.4.22,b0171,C00942,"3',5'-Cyclic GMP",lower affinity or extent of activation than GTP
540,2.7.4.22,b0171,C00144,GMP,lower affinity or extent of activation than GTP
541,2.7.4.22,b0171,C00387,Guanosine,lower affinity or extent of activation than GTP
542,2.7.4.22,b0171,C00081,ITP,
543,2.7.7.89,,C00081,ITP,"activation by nucleotides, most efficient in presence of two different nucleotides"
544,6.3.4.2,b2780,C00081,ITP,"0 mM guanosine, kact: 5.2/sec, KA: 2.9 mM, Ki: 4.5 mM; the GTP analogue is capable of activating Gln-dependent CTP formation"
545,6.3.5.5,b0032,C00081,ITP,enhances activity
546,6.3.5.5,b0033,C00081,ITP,enhances activity
547,2.7.4.22,b0171,C00700,XTP,
548,2.7.7.1,b4390,C12538,Ammonium chloride,"activation, can substitute for KCl"
549,3.6.1.24,,C12538,Ammonium chloride,180% of standard activity at 1 M
550,2.7.7.6,b3987,C00025,L-Glutamate,"glutamate remodels the sigma38 transcription complex for activation. Accumulation of the simple signaling molecule glutamate can reprogram RNA polymerase in vitro without the need for specific protein receptors. During osmotic activation, glutamate appears to act as a Hofmeister series osmolyte to facilitate promoter escape. Escape is accompanied by a remodeling of the key interaction between the sigma38 stress protein and the beta-flap of the bacterial core RNA polymerase. This activation event contrasts with the established mechanism of inhibition in which glutamate, by virtue of its electrostatic properties, helps to inhibit binding to ribosomal promoters after osmotic shock"
551,2.7.7.6,b3988,C00025,L-Glutamate,"glutamate remodels the sigma38 transcription complex for activation. Accumulation of the simple signaling molecule glutamate can reprogram RNA polymerase in vitro without the need for specific protein receptors. During osmotic activation, glutamate appears to act as a Hofmeister series osmolyte to facilitate promoter escape. Escape is accompanied by a remodeling of the key interaction between the sigma38 stress protein and the beta-flap of the bacterial core RNA polymerase. This activation event contrasts with the established mechanism of inhibition in which glutamate, by virtue of its electrostatic properties, helps to inhibit binding to ribosomal promoters after osmotic shock"
552,2.7.7.6,b3295,C00025,L-Glutamate,"glutamate remodels the sigma38 transcription complex for activation. Accumulation of the simple signaling molecule glutamate can reprogram RNA polymerase in vitro without the need for specific protein receptors. During osmotic activation, glutamate appears to act as a Hofmeister series osmolyte to facilitate promoter escape. Escape is accompanied by a remodeling of the key interaction between the sigma38 stress protein and the beta-flap of the bacterial core RNA polymerase. This activation event contrasts with the established mechanism of inhibition in which glutamate, by virtue of its electrostatic properties, helps to inhibit binding to ribosomal promoters after osmotic shock"
553,2.7.7.6,b3649,C00025,L-Glutamate,"glutamate remodels the sigma38 transcription complex for activation. Accumulation of the simple signaling molecule glutamate can reprogram RNA polymerase in vitro without the need for specific protein receptors. During osmotic activation, glutamate appears to act as a Hofmeister series osmolyte to facilitate promoter escape. Escape is accompanied by a remodeling of the key interaction between the sigma38 stress protein and the beta-flap of the bacterial core RNA polymerase. This activation event contrasts with the established mechanism of inhibition in which glutamate, by virtue of its electrostatic properties, helps to inhibit binding to ribosomal promoters after osmotic shock"
554,3.1.26.3,b2567,C00025,L-Glutamate,extends salt concentration range
555,2.7.7.19,b0143,C00575,"3',5'-Cyclic AMP",slight stimulation
556,2.7.7.27,b3430,C04442,2-Dehydro-3-deoxy-6-phospho-D-gluconate,"activation; fructose 6-phosphate and pyruvate analog, less effective than fructose bisphosphate"
557,2.7.7.27,b3430,C00109,2-Oxobutanoate,"slight activation, pyruvate analog"
558,2.7.7.27,b3430,C00597,Glycerate 3-phosphate,activation
559,2.7.7.27,b3430,C00597,Glycerate 3-phosphate,activation; pH-dependent
560,2.7.7.27,b3430,C00597,Glycerate 3-phosphate,
561,2.7.7.27,b3430,C00085,D-Fructose 6-phosphate,activation
562,2.7.7.27,b3430,C00085,D-Fructose 6-phosphate,"mainly Agrobacterium tumefaciens and chimeric enzyme AE containing the N-terminus of Agrobacterium tumefaciens enzyme and the C-terminus of Escherichia coli enzyme, not chimeric enzyme EA containing the N-terminus of Escherichia coli enzyme and the C-terminus of Agrobacterium tumefaciens enzyme"
563,2.7.7.27,b3430,C00085,D-Fructose 6-phosphate,
564,2.7.7.27,b3430,C00673,2-Deoxy-D-ribose 5-phosphate,"activation, D-fructose 6-phosphate analog"
565,2.7.7.27,b3430,C00661,Glyceraldehyde 3-phosphate,less effective than fructose bisphosphate
566,2.7.7.27,b3430,C00168,Hydroxypyruvate,"slight activation, pyruvate analog"
567,2.7.7.27,b3430,C00447,"Sedoheptulose 1,7-bisphosphate",activation; isosteric analog of fructose bisphosphate
568,2.7.7.42,b3053,C00026,2-Oxoglutarate,0.02 mM
569,2.7.7.42,b3053,C00026,2-Oxoglutarate,"1 mM; regulates both adenylyltransferase and adenylyl-removing reaction, acts through its binding to signal transduction protein PII and signal transduction protein PII-UMP does not alter the binding of signal transduction protein PII or signal transduction protein PII-UMP to the enzyme, adenylyltransferase assay with 0.05 mM and adenylyl-removing assay with 1 mM alpha-ketoglutarate"
570,2.7.7.59,b0167,C00026,2-Oxoglutarate,"at low concentration, required for PII uridylylation"
571,2.7.7.89,,C00026,2-Oxoglutarate,activation
572,4.1.2.13,b2925,C00026,2-Oxoglutarate,"enhances D-fructose 1,6-bisphosphate-cleavage activity, fructose 1-phosphate-cleavage activity is unaffected"
573,4.1.2.13,b2097,C00026,2-Oxoglutarate,"enhances D-fructose 1,6-bisphosphate-cleavage activity, fructose 1-phosphate-cleavage activity is unaffected"
574,2.7.13.3,b1888,C00122,Fumarate,effector of DcuS
575,2.7.13.3,b3404,C00122,Fumarate,effector of DcuS
576,2.7.13.3,b0400,C00122,Fumarate,effector of DcuS
577,2.7.13.3,b1129,C00122,Fumarate,effector of DcuS
578,2.7.13.3,b0695,C00122,Fumarate,effector of DcuS
579,2.7.13.3,b3210,C00122,Fumarate,effector of DcuS
580,2.7.13.3,b3026,C00122,Fumarate,effector of DcuS
581,2.7.13.3,b1222,C00122,Fumarate,effector of DcuS
582,2.7.13.3,b2469,C00122,Fumarate,effector of DcuS
583,2.7.13.3,b2216,C00122,Fumarate,effector of DcuS
584,2.7.13.3,b3668,C00122,Fumarate,effector of DcuS
585,2.7.13.3,b0570,C00122,Fumarate,effector of DcuS
586,2.7.13.3,b0619,C00122,Fumarate,effector of DcuS
587,2.7.13.3,b4125,C00122,Fumarate,effector of DcuS
588,2.7.13.3,b0993,C00122,Fumarate,effector of DcuS
589,2.7.13.3,b3911,C00122,Fumarate,effector of DcuS
590,2.7.13.3,b4112,C00122,Fumarate,effector of DcuS
591,2.7.13.3,b2218,C00122,Fumarate,effector of DcuS
592,2.7.13.3,b3869,C00122,Fumarate,effector of DcuS
593,2.7.13.3,b2219,C00122,Fumarate,effector of DcuS
594,2.7.13.3,b2556,C00122,Fumarate,effector of DcuS
595,2.7.13.3,b4003,C00122,Fumarate,effector of DcuS
596,2.7.13.3,b2370,C00122,Fumarate,effector of DcuS
597,2.7.13.3,b2078,C00122,Fumarate,effector of DcuS
598,2.7.13.3,b4399,C00122,Fumarate,effector of DcuS
599,2.7.13.3,b1609,C00122,Fumarate,effector of DcuS
600,2.7.13.3,b2786,C00122,Fumarate,effector of DcuS
601,2.7.13.3,b2126,C00122,Fumarate,effector of DcuS
602,2.7.13.3,b2380,C00122,Fumarate,effector of DcuS
603,2.7.13.3,b1968,C00122,Fumarate,effector of DcuS
604,2.8.1.6,b0775,C05378,"beta-D-Fructose 1,6-bisphosphate",
605,2.8.1.7,b2530,C00018,Pyridoxal phosphate,
606,2.8.1.7,b1680,C00018,Pyridoxal phosphate,
607,3.1.1.1,,C00175,Cobalt ion,150% activation of recombinant BioHe at 5-10 mM
608,3.1.3.1,b0383,C00038,Zinc cation,"stimulation of mutant enzymes, in presence or absence of a phosphoryl group acceptor in the reaction, except for mutnat H412Y, whose activity is reduced in presence of phosphoryl group acceptor and 0.1 mM Zn2+"
609,3.1.3.11,b3925,C00059,Sulfate,up to 300% activation
610,3.1.3.11,b4232,C00059,Sulfate,up to 300% activation
611,3.1.11.6,b0422,C00059,Sulfate,stimulates
612,3.1.11.6,b2509,C00059,Sulfate,stimulates
613,3.1.3.18,b3385,C01327,Hydrochloric acid,"the activity is 11fold increased, cooperative effect of Cl- and Mg2+"
614,4.1.1.15,b1493,C01327,Hydrochloric acid,activates
615,4.1.1.15,b3517,C01327,Hydrochloric acid,activates
616,3.1.3.27,b1278,C11166,SDS,
617,3.1.3.27,b0418,C11166,SDS,
618,3.1.3.27,b2560,C11166,SDS,
619,3.1.11.5,b2819,C00575,"3',5'-Cyclic AMP",less effective than ATP
620,3.1.11.5,b2820,C00575,"3',5'-Cyclic AMP",less effective than ATP
621,3.1.11.5,b2822,C00575,"3',5'-Cyclic AMP",less effective than ATP
622,3.1.11.5,b2819,C00147,Adenine,less effective than ATP
623,3.1.11.5,b2820,C00147,Adenine,less effective than ATP
624,3.1.11.5,b2822,C00147,Adenine,less effective than ATP
625,3.2.2.20,b3549,C00147,Adenine,
626,3.1.11.5,b2819,C13563,Sodium chloride,ATP molecules hydrolyzed per base pair unwound slightly increased
627,3.1.11.5,b2820,C13563,Sodium chloride,ATP molecules hydrolyzed per base pair unwound slightly increased
628,3.1.11.5,b2822,C13563,Sodium chloride,ATP molecules hydrolyzed per base pair unwound slightly increased
629,3.1.13.1,b1286,C01672,Cadaverine,can replace missing Mg2+ to a small extent
630,3.1.21.3,b4348,C00019,S-Adenosyl-L-methionine,stimulates DNA cleavage activity
631,3.1.21.3,b4350,C00019,S-Adenosyl-L-methionine,stimulates DNA cleavage activity
632,3.1.26.5,b3704,C07339,Quinacrine,most potent activator
633,3.1.26.5,b3704,C01457,Tylosin,
634,3.2.2.20,b3549,C07481,Caffeine,
635,3.2.2.21,b2068,C14592,N-Methyl-N'-nitro-N-nitrosoguanidine,
636,3.2.2.21,b2068,C14592,N-Methyl-N'-nitro-N-nitrosoguanidine,"MNNG, good inducer of the enzyme, methylmethanesulfonate is less effective and 4-nitroquinoline-1-oxide has no effect"
637,3.4.21.53,b0439,C13742,Adenosine 5-O-(3-thiotriphophate),"hydrolysis, peptide not protein hydrolysis; i.e. adenosine 5'-O-(thiotriphosphate) or ATP-gamma-S, activation"
638,3.4.21.53,b0439,C13742,Adenosine 5-O-(3-thiotriphophate),"i.e. adenosine 5'-O-(thiotriphosphate) or ATP-gamma-S, activation; slight"
639,3.4.21.53,b0439,C13742,Adenosine 5-O-(3-thiotriphophate),"equally effective as ATP with casein as substrate; i.e. adenosine 5'-O-(thiotriphosphate) or ATP-gamma-S, activation"
640,3.4.21.53,b0439,C13742,Adenosine 5-O-(3-thiotriphophate),"activates, hydrolysis of casein or glutaryl-Ala-Ala-Phe-methoxynaphthylamide; i.e. adenosine 5'-O-(thiotriphosphate) or ATP-gamma-S, activation; not bovine serum albumin hydrolysis"
641,3.4.21.53,b0439,C01501,Glucagon,"activation, glutaryl-Ala-Ala-Phe methoxynaphthylamide hydrolysis, with or without ATP, not casein hydrolysis"
642,3.4.23.49,b0565,C00604,"1,10-Phenanthroline",enhances activity
643,3.5.1.2,b1524,C00604,"1,10-Phenanthroline",slight activation
644,3.5.1.2,b0485,C00604,"1,10-Phenanthroline",slight activation
645,3.4.23.49,b0565,C00896,Tos-Lys-CH2Cl,increases activity
646,3.4.24.B17,,C11143,Dimethyl sulfoxide,"induces conformational changes, stimulates with SecY s substrate, at concentration up to 20% v/v, slightly inhibitory with casein as a substrate"
647,3.5.1.28,b2435,C11275,Cetyltrimethylammonium bromide,
648,3.5.1.28,b4169,C11275,Cetyltrimethylammonium bromide,
649,3.5.1.28,b2817,C11275,Cetyltrimethylammonium bromide,
650,3.5.1.28,b0867,C11275,Cetyltrimethylammonium bromide,
651,3.6.3.2,b4242,C11275,Cetyltrimethylammonium bromide,"i.e. CTAB, Mg2+-ATPase activity of ECF1 is very resistant to inhibition by cetyltrimethylammonium bromide, lower concentrations of cetyltrimethylammonium bromide stimulate Mg2+-ATPase activity of ECF1"
652,3.5.1.28,b2435,C00329,D-Glucosamine,30% activation at 10 mM
653,3.5.1.28,b4169,C00329,D-Glucosamine,30% activation at 10 mM
654,3.5.1.28,b2817,C00329,D-Glucosamine,30% activation at 10 mM
655,3.5.1.28,b0867,C00329,D-Glucosamine,30% activation at 10 mM
656,3.5.1.28,b2435,C11279,Myristyltrimethylaminium bromide,
657,3.5.1.28,b4169,C11279,Myristyltrimethylaminium bromide,
658,3.5.1.28,b2817,C11279,Myristyltrimethylaminium bromide,
659,3.5.1.28,b0867,C11279,Myristyltrimethylaminium bromide,
660,3.5.4.1,b0337,C16434,Isoleucine,"1 mM, relative activity 130%"
661,3.5.4.1,b0337,C00049,L-Aspartate,
662,3.5.4.1,b0337,C00049,L-Aspartate,"1 mM, relative activity 130%"
663,3.5.4.1,b0337,C00025,L-Glutamate,
664,3.5.4.1,b0337,C00025,L-Glutamate,"1 mM, relative activity 120%"
665,3.5.4.1,b0337,C00077,L-Ornithine,"1 mM, relative activity 120%"
666,6.3.5.5,b0032,C00077,L-Ornithine,"positive allosteric activation, E783, T1042, and T1043 are primarily responsible for the binding of ornithine to enzyme"
667,6.3.5.5,b0033,C00077,L-Ornithine,"positive allosteric activation, E783, T1042, and T1043 are primarily responsible for the binding of ornithine to enzyme"
668,6.3.5.5,b0032,C00077,L-Ornithine,"effector on ATP synthesis reaction, when ornithine is bound to the enzyme, its activation dominates the actions of UMP and IMP"
669,6.3.5.5,b0033,C00077,L-Ornithine,"effector on ATP synthesis reaction, when ornithine is bound to the enzyme, its activation dominates the actions of UMP and IMP"
670,6.3.5.5,b0032,C00077,L-Ornithine,"the effector stabilizes the (alpha,beta)4-tetramer of enzyme"
671,6.3.5.5,b0033,C00077,L-Ornithine,"the effector stabilizes the (alpha,beta)4-tetramer of enzyme"
672,6.3.5.5,b0032,C00077,L-Ornithine,binds to the enzymes large subunit at the interface located between the allosteric and the carbamoyl phosphate domains
673,6.3.5.5,b0033,C00077,L-Ornithine,binds to the enzymes large subunit at the interface located between the allosteric and the carbamoyl phosphate domains
674,6.3.5.5,b0032,C00077,L-Ornithine,allosteric effect on chimeric enzyme and Escherichia coli enzyme
675,6.3.5.5,b0033,C00077,L-Ornithine,allosteric effect on chimeric enzyme and Escherichia coli enzyme
676,6.3.5.5,b0032,C00077,L-Ornithine,
677,6.3.5.5,b0033,C00077,L-Ornithine,
678,3.5.4.5,b2143,C00475,Cytidine,
679,3.5.99.6,b0678,C00357,N-Acetyl-D-glucosamine 6-phosphate,activates; increases reaction velocity when D-glucosamine 6-phosphate is present at levels below that required for saturation
680,3.5.99.6,b0678,C00357,N-Acetyl-D-glucosamine 6-phosphate,activates
681,3.5.99.6,b0678,C00357,N-Acetyl-D-glucosamine 6-phosphate,
682,3.5.99.6,b0678,C00357,N-Acetyl-D-glucosamine 6-phosphate,allosteric activator of NagB
683,3.6.3.1,,C06026,Di[3-deoxy-D-manno-octulosonyl]-lipid A,
684,3.6.3.16,,C13619,Arsenous oxide,allosteric activation
685,3.6.3.16,,C13619,Arsenous oxide,"activates 3fold the ATPase activity of wild-type ArsA, activation rates of mutants, overview"
686,3.6.3.39,,C00588,Choline phosphate,2fold stimulation of MsbA
687,3.6.3.39,,C07394,Paclitaxel,"1.4fold stimulation of the wild-type enzyme, no stimulation of mutant S289A/S290A. Erythromycin resistance is conferred by wild-type or mutant MsbA, taxol is sufficient to reverse the erythromycin resistance of wild-type MsbA-expressing cells"
688,3.6.4.10,,C13742,Adenosine 5-O-(3-thiotriphophate),"in 1:1 mixture with ATP, greatly stimulates protein remodeling"
689,3.6.4.10,,C09094,Geranylgeraniol,presence of peptide NRLLLTG eliminates stimulatory effect
690,3.6.5.3,,C00908,Gentamicin C1a,
691,3.6.5.3,,C01822,Kanamycin A,
692,3.6.5.3,,C00825,Kanamycin B,
693,3.6.5.3,,C15652,Neomycin C,
694,3.6.5.3,,C00494,Sisomicin,
695,3.6.5.3,,C00413,Streptomycin,
696,3.6.5.3,,C00413,Streptomycin,only EF-G
697,3.6.5.3,,C00397,Tobramycin,
698,4.1.1.11,b0131,C00024,Acetyl-CoA,acetyl-CoA is required for activation
699,4.1.1.49,b3403,C00024,Acetyl-CoA,
700,4.1.1.15,b1493,C13645,Hydrobromic acid,activates
701,4.1.1.15,b3517,C13645,Hydrobromic acid,activates
702,4.1.1.15,b1493,C16487,Hydrofluoric acid,activates
703,4.1.1.15,b3517,C16487,Hydrofluoric acid,activates
704,4.1.1.15,b1493,C05590,Hydroiodic acid,activates
705,4.1.1.15,b3517,C05590,Hydroiodic acid,activates
706,4.1.1.20,b2838,C02924,Dimercaprol,activates
707,4.1.1.20,b2838,C00739,D-Lysine,activates
708,4.1.1.31,b3956,C05378,"beta-D-Fructose 1,6-bisphosphate",activates
709,4.1.1.98,b3843,C00725,Lipoate,slight (20%) stimulation of activity at 10 mM
710,4.1.2.13,b2925,C03189,DL-Glycerol 1-phosphate,"enhances D-fructose 1,6-bisphosphate-cleavage activity, fructose 1-phosphate-cleavage activity is unaffected"
711,4.1.2.13,b2097,C03189,DL-Glycerol 1-phosphate,"enhances D-fructose 1,6-bisphosphate-cleavage activity, fructose 1-phosphate-cleavage activity is unaffected"
712,4.1.3.6,,C00864,Pantothenate,contains 3.5 mol pantothenate per mol of enzyme in the acyl-carrier-protein gamma-subunit
713,4.1.99.3,b0708,C00445,"5,10-Methenyltetrahydrofolate",binds to the enzyme and acts as a light-harvesting pigment
714,4.1.99.3,b0708,C01352,FADH2,"in wild-type, substantial losses occur prior to formation of the ultimate (FADH- 306TrpH°+) charge pair but that there is no significant kinetic development in the 100 ps-to-10 ns time window. The quantum yield of FADH- W306°+ is at 19%, in reference to the established quantum yield of the long-lived excited state of [Ru(bpy)3]2+"
715,4.1.99.3,b0708,C01352,FADH2,"FADH-/FADH reduction potential of the cryptochrome1 is significantly higher than that of the photolyase at 164 mV vs normal hydrogen electrode, but it also increases upon substrate binding (to 195 mV vs normal hydrogen electrode) similar to what is observed in photolyase. FADH-/FADH reduction potential is insensitive to ATP binding"
716,4.2.1.79,b0334,C00163,Propanoate,induces the enzyme expression from acnC and prpD
717,6.3.2.10,b0086,C00163,Propanoate,strong activation of mutant K202A
718,4.2.1.104,b0340,C01417,Cyanate,"extracellular, enzyme induction"
719,4.2.3.3,b0963,C00988,2-Phosphoglycolate,activates H98Q variant
720,4.3.1.1,b4139,C00402,D-Aspartate,
721,4.3.1.1,b4139,C02532,O-Phospho-D-serine,
722,4.3.1.1,b4139,C00583,"Propane-1,2-diol",activates
723,5.1.1.3,b3967,C01212,UDP-N-acetylmuramoyl-L-alanine,absolutely required
724,5.1.1.3,b3967,C01212,UDP-N-acetylmuramoyl-L-alanine,activator
725,5.1.3.2,b0759,C00015,UDP,activates the reduction of epimerase-bound NAD+
726,5.1.3.2,b0759,C00105,UMP,activates the reduction of epimerase-bound NAD+
727,5.1.3.14,b3786,C00043,UDP-N-acetyl-alpha-D-glucosamine,allosteric activation
728,5.1.3.14,b3786,C00043,UDP-N-acetyl-alpha-D-glucosamine,the reverse reaction with UDP-N-acetylmannosamine requires the presence of UDP-N-acetylglucosamine
729,5.3.1.5,b3565,C00379,Xylitol,
730,5.3.4.1,b2893,C00127,Glutathione disulfide,promotes the activation of carbonic anhydrase IV
731,5.4.2.7,b4383,C04175,"2-Deoxy-D-ribose 1,5-bisphosphate","10fold stimulation, Km: 0.00017 mM, optimal concentration: 0.0014 mM"
732,5.4.2.7,b4383,C01151,"D-Ribose 1,5-bisphosphate","10fold stimulation, Km: 0.00017 mM, optimal concentration: 0.0014 mM"
733,5.4.2.7,b4383,C01151,"D-Ribose 1,5-bisphosphate","stimulates, Km: 0.00024 mM for enzyme form I, 0.00027 mM for enzyme form II and 0.00029 mM for enzyme form III"
734,5.4.2.11,b0755,C03339,"2,3-Bisphosphoglycerate",
735,5.4.2.11,b0755,C03339,"2,3-Bisphosphoglycerate",
736,5.4.2.12,b4395,C03339,"2,3-Bisphosphoglycerate",
737,5.4.2.12,b3612,C03339,"2,3-Bisphosphoglycerate",
738,5.4.3.8,b0154,C00189,Ethanolamine,stimulates activity of mutant enzyme Lys265Arg
739,5.99.1.2,b1274,C00088,Nitrite,acidic nitrite enhanced the bactericidal effect of stabilized topoisomerase I cleavage complex
740,5.99.1.2,b1763,C00088,Nitrite,acidic nitrite enhanced the bactericidal effect of stabilized topoisomerase I cleavage complex
741,6.1.1.19,b1876,C00986,"1,3-Diaminopropane",supports aminoacylation in presence of crude tRNA not in presence of resolved tRNA
742,6.3.1.2,b3870,C00137,myo-Inositol,"0.4 M, 70.1% residual activity after 60°C heat treatment"
743,6.3.1.2,b3870,C03844,D-Pinitol,"0.4 M, 74.2% residual activity after 60°C heat treatment"
744,6.3.1.2,b3870,C08258,(+)-Quercitol,"0.4 M, 75.5% residual activity after 60°C heat treatment"
745,6.3.1.2,b3870,C00794,D-Sorbitol,"0.4 M, 62.0% residual activity after 60°C heat treatment"
746,6.3.2.10,b0086,C00246,Butanoic acid,activation of mutant K202A
747,6.3.4.2,b2780,C00286,dGTP,"0 mM guanosine, kact: 1.5/sec, KA: 0.21 mM, Ki: 0.36 mM; the GTP analogue is capable of activating Gln-dependent CTP formation"
748,6.3.4.14,b3256,C00120,Biotin,"required for activation of the ATP synthesis reaction with carbamoyl phosphate and ADP as substrates, E211, E288, N290 and R292 are responsible, at least in part, for the substrate-induced synergism by biotin, activation via a conformational change of enzyme"
749,6.3.4.14,b3256,C00120,Biotin,activates the ATP synthesis reaction with ADP and carbamoyl phosphate as substrates
750,6.3.4.14,b3256,C00120,Biotin,"substrate-induced synergism, the reaction in presence of biotin is 1100fold faster than in its absence"
751,6.4.1.2,b2316,C00120,Biotin,"required for subunit AccB activity, biotin is not involved in regulation of operon accBC transcription"
752,6.4.1.2,b0185,C00120,Biotin,"required for subunit AccB activity, biotin is not involved in regulation of operon accBC transcription"
753,6.4.1.2,b3256,C00120,Biotin,"required for subunit AccB activity, biotin is not involved in regulation of operon accBC transcription"
754,6.4.1.2,b2316,C00120,Biotin,required for activity
755,6.4.1.2,b0185,C00120,Biotin,required for activity
756,6.4.1.2,b3256,C00120,Biotin,required for activity
757,6.3.4.16,,C00130,IMP,"weak activator, the IMP binding site is located at the C-terminus, binding structure analysis from crystal structure with bound IMP, PDB ID 1CE8"
758,6.3.4.16,,C00077,L-Ornithine,
759,6.3.5.5,b0032,C00077,L-Ornithine,
760,6.3.5.5,b0033,C00077,L-Ornithine,
761,6.3.5.5,b0032,C00077,L-Ornithine,"co-substrate with carbamoyl phosphate for the second step of arginine biosynthesis, acts as a positive allosteric effector for eCPS, the catalyst for the first pathway step"
762,6.3.5.5,b0033,C00077,L-Ornithine,"co-substrate with carbamoyl phosphate for the second step of arginine biosynthesis, acts as a positive allosteric effector for eCPS, the catalyst for the first pathway step"
763,6.3.5.5,b0032,C00014,Ammonia,
764,6.3.5.5,b0033,C00014,Ammonia,
765,6.3.5.5,b0032,C00130,IMP,allosteric effector
766,6.3.5.5,b0033,C00130,IMP,allosteric effector
767,6.3.5.5,b0032,C00130,IMP,"His995, located in the C-terminal regulatory domain, is cross-linked with IMP"
768,6.3.5.5,b0033,C00130,IMP,"His995, located in the C-terminal regulatory domain, is cross-linked with IMP"
769,6.3.5.5,b0032,C00130,IMP,"the effector stabilzes the (alpha,beta)4-tetramer of enzyme"
770,6.3.5.5,b0033,C00130,IMP,"the effector stabilzes the (alpha,beta)4-tetramer of enzyme"
771,6.3.5.5,b0032,C00130,IMP,"allosteric effect on Escherichia coli enzyme in dependence of temperature, no response to chimeric enzyme"
772,6.3.5.5,b0033,C00130,IMP,"allosteric effect on Escherichia coli enzyme in dependence of temperature, no response to chimeric enzyme"
773,6.3.5.5,b0032,C00130,IMP,
774,6.3.5.5,b0033,C00130,IMP,
775,6.3.5.5,b0032,C00130,IMP,the IMP activator and the UMP inhibitor bind to the same site on the enzyme
776,6.3.5.5,b0033,C00130,IMP,the IMP activator and the UMP inhibitor bind to the same site on the enzyme
777,6.3.5.5,b0032,C00624,N-Acetyl-L-glutamate,carbamoyl-phosphate synthase II: no requirement for N-acetylglutamate
778,6.3.5.5,b0033,C00624,N-Acetyl-L-glutamate,carbamoyl-phosphate synthase II: no requirement for N-acetylglutamate
779,6.3.5.5,b0032,C02441,N-Ethylmaleimide,250fold activation of glutaminase activity. Irreversible inactivation of synthetase activity
780,6.3.5.5,b0033,C02441,N-Ethylmaleimide,250fold activation of glutaminase activity. Irreversible inactivation of synthetase activity
781,6.3.5.5,b0032,C00077,L-Ornithine,allosteric activation
782,6.3.5.5,b0033,C00077,L-Ornithine,allosteric activation
783,6.3.5.5,b0032,C00077,L-Ornithine,activates
784,6.3.5.5,b0033,C00077,L-Ornithine,activates
785,6.3.5.5,b0032,C00238,Potassium cation,
786,6.3.5.5,b0033,C00238,Potassium cation,
787,6.3.5.5,b0032,C00655,Xanthosine 5'-phosphate,enhances activity
788,6.3.5.5,b0033,C00655,Xanthosine 5'-phosphate,enhances activity
